Lazard Asset Management’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-681
Closed 2493
2024
Q2
$0 Sell
681
-124,797
-99% -$74.4K ﹤0.01% 2469
2024
Q1
$104K Sell
125,478
-11,142
-8% -$7.63K ﹤0.01% 1522
2023
Q4
$53K Sell
136,620
-3,080
-2% -$2.46K ﹤0.01% 1875
2023
Q3
$223K Sell
139,700
-4,230
-3% -$11.7K ﹤0.01% 1355
2023
Q2
$420K Sell
143,930
-139
-0.1% -$315 ﹤0.01% 1163
2023
Q1
$348K Buy
144,069
+1,270
+0.9% +$3.52K ﹤0.01% 1179
2022
Q4
$267K Sell
142,799
-122,199
-46% -$191K ﹤0.01% 1244
2022
Q3
$339K Buy
264,998
+13,837
+6% +$30.1K ﹤0.01% 1163
2022
Q2
$615K Buy
251,161
+86,344
+52% +$411K ﹤0.01% 1076
2022
Q1
$1.14M Buy
164,817
+38,892
+31% +$412K ﹤0.01% 983
2021
Q4
$2M Buy
125,925
+65,042
+107% +$1.3M ﹤0.01% 931
2021
Q3
$1.22M Buy
60,883
+2,865
+5% +$73.9K ﹤0.01% 1029
2021
Q2
$1.79M Buy
58,018
+57,119
+6,354% +$1.71M ﹤0.01% 863
2021
Q1
$23K Buy
+899
New +$22.5K ﹤0.01% 1717

Other funds holding RNLX

Lazard Asset Management's RNLX Position: Q3 2024 in Review

Lazard Asset Management sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2024, closing a stake of 681 shares.

Lazard Asset Management first reported a position in RNLX in Q1 2021 and held it in 14 quarters. The position peaked at $2M in Q4 2021. 24 funds tracked by Wall St. Rank hold RNLX as of Q3 2024.

  • Lazard Asset Management reported no remaining Renalytix plc American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Lazard Asset Management sold 681 Renalytix plc American Depositary Shares shares in Q3 2024.
  • Lazard Asset Management first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 14 quarters.
  • Lazard Asset Management's Renalytix plc American Depositary Shares position peaked at $2M in Q4 2021.
  • 24 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2024.

Based on Lazard Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.